When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ACST - Acasti Pharma under pressure on diminished expectations for second pivotal CaPre study
Acasti Pharma Inc.
Acasti Pharma (NASDAQ:ACST) will host a conference call on Monday, June 29, at 1:00 pm ET to provide more details on its post hoc analyses of the failed Phase 3 TRILOGY 1 study evaluating CaPre (omega-3 phospholipid) for the treatment of hypertriglyceridemia (high levels of triglycerides in the blood).
More news on: Acasti Pharma Inc., Healthcare stocks news, Stocks on the move,